Events

IBA Lifesciences and Gator Bio collaborated on the newly launched Strep-Tactin®XT probes - ready-to-use Strep-Tactin®XT-covered biosensors for BLI (Biolayer Interferometry). They allow capturing and subsequent quantitation and kinetic analysis of Twin-Strep-tag® fusion proteins.

Gator Bio is offering the whole range of products as devices, software and consumables for Biolayer Interferometry analysis - a label-free, real-time measurement of biomolecules.

Strep-Tactin®XT is an engineered streptavidin and part of IBA Lifesciences’ 3rd generation versatile Strep-tag® system. It exhibits strong (pM range), but reversible binding to the Twin-Strep-tag® peptide, allowing all kinds of protein analytic applications.

The corresponding application note is planned for early autumn 2023. The product is already available for order .

IBA Lifesciences and IMCS collaborated for the development of new product, which combines Strep-Tactin®XT with the IMCStips® allowing an automated, fast, and efficient purification of Strep-tagged proteins. IMCS provides with its IMCStips® a dispersive pipette extraction technology which streamlines the protein and peptide sample preparation process through automation. It can be applied across many different automation platforms and ALH devices.

Combined with IBA’s unique Strep-tag®:Strep-Tactin®-system, which is one of the most widely used systems for affinity protein purification, the IMCStips® XT HC allows a fast, efficient and autonomous way to purify Strep-tagged proteins. The corresponding application note by IMCS provides additional information and insights into the technology and its’ benefits with the focus on optimizing binding capacity and elution parameters.

For more information please feel free to contact us at: strep-tag@iba-lifesciences.com

Our powerful resins, Strep-Tactin®XT 4Flow® and Strep-Tactin®XT 4Flow® high capacity, replace Strep-Tactin®XT Superflow® as well as Strep-Tactin®XT Superflow® high capacity as of July 1st, 2021. In comparison to Strep-Tactin®XT Superflow® resins, Strep-Tactin®XT 4Flow® resins have improved and enhanced properties and are, therefore, our Strep-Tactin®XT resins for the future.

Strep-Tactin®XT 4Flow® and the high capacity variant are perfectly suitable for efficient protein purification independent from the protein class, including challenging proteins, low abundant proteins and especially large proteins. Furthermore, the broad pH stability enhanced the compatibility with different buffer compositions.

The new structure organizes IBA Lifesciences’ core business operations around two strategic departments: Protein Production & Assays and Cell Selection & Expansion. These product lines are united by IBAs’ proprietary and versatile platform, the Strep-tag® technology.

As part of this process, IBA will discontinue the production of custom oligonucleotides. All employees of the Custom Oligo & Predefined DNA/RNA department will be merged into the remaining two departments. As a result, this will strengthen the production as well as research and development of the protein production and cell selection tools.

The Custom Oligos & Predefined DNA/RNA department has served IBAs’ customers with specialized nucleic acid products and oligonucleotides since 1998. The company is extremely proud of all the accomplishments of the department in those years. Existing orders will be honored and IBA is working hard to ensure a timely delivery of the products.

Mike Rothe, IBA’s CEO said, “Focusing on our core technology will help us expand into promising new product areas, such as the field of exosome isolation. This is a key step in our strategic, long-term plan to better meet the demands of our globally expanding businesses, especially in Asia. The current re-allocation of resources will enable us to respond very quickly to the increasing demand of protein production and cell selection tools. This will result in major changes in efficiencies and position us well for future success.”

The company will begin to implement the restructuring immediately, and the reorganization is expected to be completed by September 2020.

About IBA Lifesciences

Founded in 1996, IBA Lifesciences is a biotechnology company providing products and custom specific services for life science applications in academia and industry worldwide. IBA’s portfolio includes tools for cell selection and expansion as well as protein production and assays.

Contact details

Anna Färger

Director Marketing / PR

IBA Lifesciences GmbH

Rudolf-Wissell-Str. 28, 37079 Goettingen, Germany

+49 (0)551 50672-0

info@iba-lifesciences.com

www.iba-lifesciences.com